KIP Infrastructure
2.27.3 -
This page is part of the KIP Infrastructure (v2.27.3: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
| Official URL: https://kip.rkkp.dk/fhir/ValueSet/ATCImmunotherapyCLL | Version: 2.27.3 | |||
| Active as of 2022-07-13 | Computable Name: ATCImmunotherapyCLL | |||
ATC koder immunterapi - [CLL]
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
This value set includes codes based on the following rules:
https://kip.rkkp.dk/fhir/CodeSystem/GenericValues version 📦2.27.3| Code | Display | Definition |
| none | Ingen immunterapi | None - used to choose none of the available values |
| other | Andet | Other - used to choose unspecific value not in a valueset |
https://kip.rkkp.dk/fhir/CodeSystem/ATC version 📦2.27.3
| Code | Display | Definition |
| L04AA34 | Alemtuzumab | L04AA34 - alemtuzumab |
| L01FA01 | Rituximab | L01FA01 - rituximab |
| L01FA02 | Ofatumumab | L01FA02 - ofatumumab |
| L01FA03 | Obinutuzumab | L01FA03 - obinutuzumab |
Expansion performed internally based on:
This value set contains 6 concepts
| System | Code | Display (en) | Definition | JSON | XML |
https://kip.rkkp.dk/fhir/CodeSystem/GenericValues | none | Ingen immunterapi | None - used to choose none of the available values | ||
https://kip.rkkp.dk/fhir/CodeSystem/GenericValues | other | Andet | Other - used to choose unspecific value not in a valueset | ||
https://kip.rkkp.dk/fhir/CodeSystem/ATC | L04AA34 | Alemtuzumab | L04AA34 - alemtuzumab | ||
https://kip.rkkp.dk/fhir/CodeSystem/ATC | L01FA01 | Rituximab | L01FA01 - rituximab | ||
https://kip.rkkp.dk/fhir/CodeSystem/ATC | L01FA02 | Ofatumumab | L01FA02 - ofatumumab | ||
https://kip.rkkp.dk/fhir/CodeSystem/ATC | L01FA03 | Obinutuzumab | L01FA03 - obinutuzumab |